Broadcom seeks more than $60bn in debt to fund AI chips for Anthropic

Broadcom is reportedly in talks with lenders to raise over $60B in new debt to fund AI chip production for Anthropic and other customers, with discussions that could lift total financing to as much as $100B. While terms are not finalized and talks are ongoing, the scale suggests strong financing capacity for AI-related capex, which is supportive for expectations around AI chip demand.

Analysis

The market should read this as a balance-sheet decision, not just an AI demand story. If Broadcom is willing to add leverage to secure AI chip volume, it implies the opportunity set is strong enough to justify funding working capital/capex ahead of cash receipts — bullish for revenue visibility, but it also converts what has been a high-quality FCF compounder into a more capital-intensive story.

The first-order beneficiaries are Broadcom’s own AI revenue trajectory and, by extension, any lender willing to syndicate paper into a large-cap tech credit with sticky cash flow. The second-order loser is the company’s premium multiple: investors pay up for AVGO because of disciplined capital returns, and extra debt can slow buybacks or raise sensitivity to any hiccup in customer demand. That matters more than the headline because the stock’s valuation has been partly anchored by FCF conversion, not just growth.

Competitively, this is a subtle negative for GPU-centric and custom-silicon rivals like NVDA and MRVL if the financing helps Broadcom win bespoke inference design slots that would otherwise stay with general-purpose accelerators. The contrarian risk is that debt-funded demand can masquerade as durable demand; if the end customers do not expand utilization fast enough, leverage becomes a timing mismatch, not a moat. The key falsifiers over 1-3 months are deal terms, rating-agency reaction, and whether management preserves buyback/dividend cadence; over 6-18 months, watch for AI revenue concentration and any margin dilution from financing costs.

Key Decisions for Investors

• Buy AVGO only on a 2-4% pullback after financing terms are disclosed; target 8-12% upside if the raise is low-cost and management reiterates free-cash-flow growth. Cut if net leverage moves materially above 3.5x or capital returns are paused.
• Pair long AVGO / short NVDA for 1-3 months to express relative share gain in custom AI silicon versus commodity GPU exposure. The trade fails if NVDA guidance re-accelerates or AVGO’s financing proves more dilutive than expected.
• Use SMH or SOXX as a hedge against an industry-wide rerating if the market starts pricing broader leverage creep across semis. This is a cleaner expression than a naked AVGO short if the broader AI tape remains strong.
• Set an alert on AVGO debt pricing and CDS: if new issuance comes 100-150 bps wider than top-tier tech IG, reduce exposure as the market is signaling the capital-return story is weakening.